CervoMed Inc
CRVO - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$21.47M
Close$
$0.91
35.9% downside
Current Fair Value
35.9% downsideOvervalued by 35.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $21.47 Million |
|---|---|
| Enterprise Value | $15.41 Million |
| Earnings per Share | $-2.98 |
| Beta | -4.3 |
| Outstanding Shares | 15,119,096 |
Return
| Return on Equity | -164.32% |
|---|---|
| Return on Assets | -133.70% |
| Return on Invested Capital | -168.39% |
Valuation & Multiples
| P/E Ratio | -0.51 |
|---|---|
| PEG | 2.17 |
| Price to Sales | - |
| Price to Book Ratio | 1.42 |
| Enterprise Value to Revenue | 1765.91 |
| Enterprise Value to EBIT | -0.53 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 6, 2026
EPS Estimate
$-0.49
Consensus analyst estimateRevenue Estimate
$50,000
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.38%▼ 16.68% |
|---|---|
| Total Invested | $114,515▼ 97.89% |
| Investors Holding | 2▼ 35.00% |
About CervoMed Inc
18 employees
diffusion pharmaceuticals is a clinical stage company focused on improving the effectiveness of standard-of-care therapies for life-threatening treatment-resistant solid cancerous tumors, without adding harmful side effects. the company ...